TB control for foreign-born people living in Japan.
-Pre-entry screening of active TB and how to follow-up people with LTBI post-entry

Background
There is a convergence of tuberculosis (TB) in Japan from the increase of TB among Japanese elderly
TB and the growing number of foreign-born persons (FB) TB living in Japan.
In Japan, the number of newly registered TB patients of FB origin exceeded 10% for the first time in2018, and the ratio of newly registered FB TB patients in their 20s was particularly high at 70.4%. The
increase in young FB TB patients is likely due to increasing international student admissions andtechnical intern trainees from higher TB burden countries. In contrast, Europe and the United States,
which are countries with low TB burden, the proportion of newly registered TB patients of FB(immigrants) is 50 to 90%, which is considerably higher than in Japan.
Japan’s birthrate is declining and the population is aging rapidly. As a result, dependency on foreignlabor is expected to increase. In the "Revised Immigration Control Act (Immigration Act)" enacted inDecember 2018, the status of residence "Specific Skills (No. 1 and No. 2)" was newly established, andthe acceptance of foreign workers was expanded.
Currently, the COVID-19 pandemic restricts international travel around the world. Similarly, international
students and trainees are not currently allowed to enter Japan. However, with control of the COVID-19
pandemic, it is expected that migrant entry will resume, despite a potentially worse global TB situation
caused by the COVID-19 pandemic.
As a measure to stop active TB prior to Japan entry, migrants from 6 countries such as the Philippines,
China, Vietnam, Nepal, Indonesia, and Myanmar, who stay for 90 days or more, a non-TB certificate
are required to issue a visa. On the other hand, the FB from high TB burden countries are thought tohave a higher TB infection rate than those in Japan, but are not tested for latent tuberculosis infection(LTBI) before or after entering Japan. In some countries where TB prevalence is low, LTBI testing for
FB (immigrants) are performed at pre and post-entry of the countries. With the forecasted increased ofFB persons in Japan, LTBI screening and TB prevention of migrants in Japan should be considered as
an important public health intervention for current control and long-term elimination of TB in Japan.

Meeting object:
To build on prior meetings on TB control among FB persons living in Japan, this meeting will focus on
specific approaches to pre- and post-entry LTBI screening for FB and mechanisms and policies forfollow-up used successfully in other countries that may be applicable to Japan as a long-term strategy.

ストップ結核パートナーシップ日本 〒101-0061 東京都千代田区三崎町 1-3-12 結核予防会内 Stop TB Partnership Japan 13-12, Misaki-cho, Chiyoda-ku, Tokyo, 101-0061, JAPAN Tel 03 5282 3010 Fax 03 5980 8267 www.stoptb.jp
info@stoptb.jp

Meeting Style: Hybrid Zoom Webinar
Language: Japanese ⇔ English interpretation (2 interpreters)
Time and Date:•

9:00 – 12:00 a.m. 31 October 2020, Saturday (Tokyo)•

20:00 –23:00 p.m. 30 October 2020, Friday (Atlanta, Germantown, USA)•

17:00 –20:00 p.m. 30 October 2020, Friday (California, USA)•

8:00 – 11:00 a.m. 31 October 2020, Saturday (Singapore)

Participants••

Speakers and Co-chairs•

Toru Mori, MD, Research Institute of TB, Tokyo, Stop TB Partnership Japan, Co-Chair•Loyce Masae Kawamura, MD, QIAGEN USA, Co-chair•

Drew Posey, MD, CDC USA•Seiya Kato, MD, Director of Research Institute of TB, Tokyo•

Akihiro Ohkado, MD, Research Institute of TB, Tokyo•

Jin Takasaki, MD, National Center for Global Health and Medicine•Omura, Secretary General, the Japanese Language School

Discussion with Japanese TB Experts (TBD)

Sponsor: Stop TB Partnership Japan. Co-sponsor: QIAGEN

ストップ結核パートナーシップ日本 〒101-0061 東京都千代田区三崎町 1-3-12 結核予防会内 Stop TB Partnership Japan 13-12, Misaki-cho, Chiyoda-ku, Tokyo, 101-0061, JAPAN Tel 03 5282 3010 Fax 03 5980 8267 www.stoptb.jp
info@stoptb.jp

AGENDATime:
9:00 – 9:15

Opening

Dr. Toru Mori RIT

address(STBJ)

Objects of this meeting

Dr. Loyce Masae
Kawamura (QIAGEN)
9:15 – 9:20

Introduction

9:20 – 9:50

Session 1

9:50 – 10:20

Dr. Drew Posey

The current US immigration pre-entry guidelines for(US CDC)

active TB and LTBI screening (draft)

Dr. Seiya Kato

Overview of current situations of TB control for foreign-(RIT JATA)

born people in Japan, its problems to be solved in thefuture

10:20 – 10:40

10:40 -10:50

Break

10:50 – 11:10

Session 2

11:10 – 11:30

Dr. Akihiro Ohkado

Overview of TB control by LTBI screening of foreign-(RIT JATA)

born people

Dr. Jin Takasaki (NCGM

Necessity of LTBI test from the viewpoint of medicalJapan)

experience for foreign-born tuberculosis patientsMs. Omura (JapaneseMy experience on TB outbreak at my school.

language school)
11:30 – 11:50

Discussion

11:50 - 12:00

Wrap upDr. Mori
Dr. Kawamura

ストップ結核パートナーシップ日本 〒101-0061 東京都千代田区三崎町 1-3-12 結核予防会内 Stop TB Partnership Japan 13-12, Misaki-cho, Chiyoda-ku, Tokyo, 101-0061, JAPAN Tel 03 5282 3010 Fax 03 5980 8267 www.stoptb.jp
info@stoptb.jp